Predictive biomarkers for the efficacy of cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocarcinoma: a prospective multicenter phase 2 trial
Crossref DOI link: https://doi.org/10.1007/s12032-014-0226-y
Published Online: 2014-09-19
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xiaotian
Xu, Jianming
Liu, Huilong
Yang, Lin
Liang, Jun
Xu, Nong
Bai, Yuxian
Wang, Jiejun
Shen, Lin
Text and Data Mining valid from 2014-09-19